Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer
Clinical trial NCT05420584 · UNKNOWN
Trial details
- NCT number
- NCT05420584
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2024-11-30
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.